Equinostic is the first company focusing on integrated diagnostic systems solutions for inflammation markers called acute phase proteins.

Equinostic develop, manufacture and market acute phase protein markers and apparatus for diagnostic and research use.

Investor

Technology Innovation invests in technology-based ideas with great commercial potential.